scholarly journals The effect of vitamin D on the development and course of breast cancer (literature review)

2021 ◽  
Vol 4 (1) ◽  
pp. 19-29
Author(s):  
M.V. Pavlushenko ◽  
R.V. Lyubota ◽  
O.S. Zotov ◽  
M.F. Anikusko ◽  
R.I. Vereshchako

Breast cancer is the most common cancer among the female population worldwide. The incidence of breast cancer is increasing every year. This requires the search for new trigger factors that can contribute to the onset and course of this disease. One of these factors is vitamin D, which is constantly deficient in most of the world’s population. This article provides a review of clinical studies over the last 15 years on the relationship between serum vitamin D concentration and breast cancer risk, prognostic factors, survival and treatment outcomes, and the effect of vitamin D receptor status on breast cancer. Studies have shown heterogeneity in research results that found the relationship between low vitamin D levels and breast cancer risk, prognostic factors and survival. There was no heterogeneity in studies showing an association between decreased vitamin D receptor status and worse prognosis. The situation was similar when studying the effect of vitamin D on impro­ving treatment outcomes. Despite conflicting research results, most studies show a correlation between vitamin D deficiency and breast cancer risk, prognostic factors, survival and treatment outcomes. Therefore, the selected vector of scientific researches is rational both from the point of view of eliminating the pandemic of vitamin D deficiency among the world’s population and preventing the spread of breast cancer.

2008 ◽  
Vol 115 (3) ◽  
pp. 629-633 ◽  
Author(s):  
P. Gapska ◽  
R. J. Scott ◽  
P. Serrano-Fernandez ◽  
T. Huzarski ◽  
T. Byrski ◽  
...  

2011 ◽  
Vol 44 (13) ◽  
pp. S206
Author(s):  
Ataee Rahele ◽  
Halalkhor Sohrab ◽  
Moslemi Daryosh ◽  
GholizadehPasha AbdulRahim ◽  
Mahmodi Toraj ◽  
...  

2018 ◽  
Vol 70 (5) ◽  
pp. 804-820 ◽  
Author(s):  
Jessica L. Tommie ◽  
Susan M. Pinney ◽  
Laurie A. Nommsen-Rivers

PLoS ONE ◽  
2015 ◽  
Vol 10 (10) ◽  
pp. e0141562 ◽  
Author(s):  
Muhammad Usman Rashid ◽  
Merium Muzaffar ◽  
Faiz Ali Khan ◽  
Maria Kabisch ◽  
Noor Muhammad ◽  
...  

2017 ◽  
Vol 11 ◽  
pp. 117822341774981 ◽  
Author(s):  
Manar Atoum ◽  
Foad Alzoughool

Vitamin D (the sunshine vitamin) plays a vital role in calcium homeostasis, skeletal metabolism, and immune, cardiovascular, and reproductive systems’ functions. The worldwide prevalence of vitamin D deficiency is approximately 1 billion. Vitamin D deficiency is a serious health problem with numerous health consequences; it is associated with diabetes, rheumatic arthritis, Parkinson, Alzheimer diseases, osteomalacia, osteoporosis, and fractures in adults and cancers. Many reports showed an inverse association between serum vitamin D concentration and incidence of several cancers, including breast, colorectal, kidney, lung, and pancreatic. About 20 different cancers have incidence rates inversely related to solar UV-B doses and serum vitamin D concentration. Considering the rising incidence of breast cancer and high prevalence of vitamin D deficiency, this review aimed to reflect an association between serum vitamin D concentration and breast cancer risk, reveal the link between vitamin D receptor genetic polymorphisms and breast cancer risk, and review the relationship between vitamin D level, breast cancer risk, and prognostic factors such as tumor stage, grade, size, lymph node involvement, and hormone receptor status.


2005 ◽  
Vol 41 (8) ◽  
pp. 1164-1169 ◽  
Author(s):  
Lorraine C. Lowe ◽  
Michelle Guy ◽  
Janine L. Mansi ◽  
Clare Peckitt ◽  
Judith Bliss ◽  
...  

Author(s):  
Issam Francis ◽  
Noora AlAbdali ◽  
Kusum Kapila ◽  
Bency John ◽  
Rabeah Abbas Al-Temaimi

Abstract. Vitamin D deficiency is an emerging risk factor for breast cancer suggesting its role in breast cancer pathogenesis. Recent evidence suggests vitamin D receptor (VDR) expression is a prognosis predictor in breast cancer. We set out to determine the status of VDR expression in histologically characterized breast cancers, and whether common genetic variants modify VDR expression in breast cancer. One-hundred and twenty Kuwaiti female breast cancer fixed tissues were assessed for VDR expression to identify the level and location of its expression by immunohistochemistry. VDR variants (rs731236, rs2228570), and vitamin D binding protein ( VDBP) variants (rs4588, rs7041) genotypes were ascertained in breast cancer specimens using Taqman genotyping assays. VDR nuclear expression correlated with low grade tumors (p = 0.01), whereas cytoplasmic expression correlated with lymph node positive tumors (p = 0.03). Absence of VDR expression was a marker for high-grade dedifferentiated tumors (p = 0.01). VDBP rs7041 associated with breast cancer risk (OR 1.92, 95% CI: 1.34 – 2.73; p = 0.0004), and VDR rs2228570 correlated with increased VDR cytoplasmic expression (p < 0.0001). In conclusion, VDR expression is altered in breast cancer confirming its involvement in breast cancer progression. Genetic factors appear to play a role in breast cancer risk, and may modify tumor sensitization to vitamin D.


2004 ◽  
Vol 10 (16) ◽  
pp. 5472-5481 ◽  
Author(s):  
Michelle Guy ◽  
Lorraine C. Lowe ◽  
Deborah Bretherton-Watt ◽  
Janine L. Mansi ◽  
Clare Peckitt ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document